Small artery remodelling in hypertension

Basic and Clinical Pharmacology and Toxicology

Volumn 110, Issue 1, 2012, Pages 49-55

  Mulvany, Michael J ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASODILATOR AGENT;

ANGIOGENESIS; ARTERY; BLOOD VESSEL REMODELLING; ESSENTIAL HYPERTENSION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RESISTANCE BLOOD VESSEL; SHORT SURVEY; TUNICA MEDIA; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIOLES; HUMANS; HYPERTENSION; PROGNOSIS; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 83455256342     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00758.x     Document Type: Short Survey

References (65)

1. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004;27:193-202.
2. Lund-Johansson P. Haemodynamics in essential hypertension. Clin Sci 1980;59:343-54.
3. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999;34:724-8.
4. Deng LY, Li JS, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci Colch 1995;88:611-22.
5. Shimbo D, Muntner P, Mann D, Viera AJ, Homma S, Polak JF et al. Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension 2010;55:1210-6.
6. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999;33:998-1001.
7. Dustan HP. History of Clinical Hypertension: from 1827 to 1970. In: Oparil S, Weber MA, (eds). Hypertension. Saunders, W.B., Philadelphia, PA, 2000; 1-4.
8. Oparil S, Izzo JL Jr. Pulsology rediscovered: commentary on the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1162-3.
9. Mulvany MJ. Small artery remodelling in hypertension: causes, consequences and therapeutic implications. Med Biol Eng Comput 2008;46:461-7.
10. Folkow B. Structural, myogenic, humoral and nervous factors controlling peripheral resistance. In: Harington M (ed.). Hypotensive Drugs. Pergamon, London, 1956;163-74.
11. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature 1976;260:617-9.
12. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978;43:854-64.
13. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987;61:181-6.
14. Falloon BJ, Heagerty AM. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994;24:16-23.
15. Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertens 1992;10:437-44.
16. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996;28:785-90.
17. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension - dual processes of remodeling and growth. Hypertension 1993;21:391-7.
18. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL et al. Vascular remodelling (Letter to Editor). Hypertension 1996;28:505-6.
19. Rosei EA, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML et al. Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995;13:341-7.
20. Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G et al. Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens 2008;26:1427-34.
21. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and on small artery structure. Hypertension 1994;23:659-66.
22. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003;108:2230-5.
23. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-41.
24. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39:10-5.
25. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001;103:1238-44.
26. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002;106:3037-43.
27. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007;25:1021-6.
28. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005;23:247-50.
29. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE et al. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 2007;20:846-52.
30. Khavandi K, Greenstein AS, Sonoyama K, Withers S, Price A, Malik RA et al. Myogenic tone and small artery remodelling: insight into diabetic nephropathy. Nephrol Dial Transplant 2009;24:361-9.
31. Eftekhari A, Mathiassen ON, Buus NH, Gotzsche O, Mulvany MJ, Christensen KL. Disproportionally impaired microvascular structure in essential hypertension. J Hypertens 2011;29:896-905.
32. Schafer S, Kelm M, Mingers S, Strauer BE. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002;20:1431-7.
33. Buus NH, Bottcher M, Jorgensen CG, Christensen KL, Thygesen K, Nielsen TT et al. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension 2004;44:465-70.
34. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003.
35. Bakker EN, van Der Meulen ET, Spaan JA, VanBavel E. Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol 2001;278:H1233-40.
36. Bakker EN, van Der Meulen ET, van den Berg BM, Everts V, Spaan JA, VanBavel E. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 2002;39:12-20.
37. Bakker EN, Buus CL, VanBavel E, Mulvany MJ. Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling. J Vasc Res 2004;41:174-82.
38. Martinez-Lemus LA, Hill MA, Bolz SS, Pohl U, Meininger GA. Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: implications for functional remodeling. FASEB J 2004;18:708-10.
39. Heerkens EH, Shaw L, Ryding A, Brooker G, Mullins JJ, Austin C et al. alphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension 2006;47:281-7.
40. Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002;27:534-9.
41. Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature's biological glues. Biochem J 2002;368:377-96.
42. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM et al. Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005;96:119-26.
43. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, van RN et al. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 2006;99:86-92.
44. Pistea A, Bakker EN, Spaan JA, Hardeman MR, van RN, VanBavel E. Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases. J Vasc Res 2008;45:10-8.
45. Bakker EN, Matlung HL, Bonta P, de Vries CJ, van RN, VanBavel E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 2008;78:341-8.
46. Matlung HL, Bakker EN, VanBavel E. Shear stress, reactive oxygen species, and arterial structure and function. Antioxid Redox Signal 2009;11:1699-709.
47. Bakker EN, Pistea A, VanBavel E. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 2008;45:271-8.
48. Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, Aalkjaer C et al. Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res 2007;44:471-82.
49. Vecchione C, Fratta L, Rizzoni D, Notte A, Poulet R, Porteri E et al. Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation 2002;105:1700-7.
50. Jacobsen JC, Mulvany MJ, Holstein-Rathlou NH. A mechanism for arteriolar remodeling based on maintenance of smooth muscle cell activation. Am J Physiol Regul Integr Comp Physiol 2008;294:R1379-89.
51. Bakker EN, Versluis JP, Sipkema P, VanTeeffelen JW, Rolf TM, Spaan JA et al. Differential structural adaptation to haemodynamics along single rat cremaster arterioles. J Physiol 2003;548:549-55.
52. Pries AR, Reglin B, Secomb TW. Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli. Hypertension 2005;46:725-31.
53. Gleason RL, Humphrey JD. A mixture model of arterial growth and remodeling in hypertension: altered muscle tone and tissue turnover. J Vasc Res 2004;41:352-63.
54. Martinez-Lemus LA, Hill MA, Meininger GA. The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure. Physiology (Bethesda) 2009;24:45-57.
55. Lee RM, Sandow SL, Demey JG. Vascular remodeling arterioles: plasticity of the vessel wall. Physiology (Bethesda) 2009;24:271-2.
56. Sorop O, Bakker EN, Pistea A, Spaan JA, VanBavel E. Calcium channel blockade prevents pressure-dependent inward remodeling in isolated subendocardial resistance vessels. Am J Physiol Heart Circ Physiol 2006;291:H1236-45.
57. Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens 2001;19:1001-6.
58. Mathiassen ON, Buus NH, Larsen ML, Mulvany MJ, Christensen KL. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 2007;25:1027-34.
59. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J Hypertens 2009;27:1107-14.
60. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982;62:347-504.
61. Kaplan NM. Clinical trials for hypertension: expectations fulfilled and unfulfilled. Hypertension 2007;49:257-9.
62. Schiffrin EL. Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature. J Cell Mol Med 2010;14:1018-29.
63. Mathiassen ON, Buus NH, Olsen HW, Larsen ML, Mulvany MJ, Christensen KL. Forearm plethysmography in the assessment of vascular tone and resistance vasculature design: new methodological insights. Acta Physiol (Oxf) 2006;188:91-101.
64. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993;22:523-6.
65. Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, Aalkjaer C et al. Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res 2007;44:471-82.